The $10 billion Tokyo-based acquirer makes mainly nutritional additives and foods, but sees Grove City’s Forge as a launchpad for expanding its healthcare arm into advanced medicine.
Forge Biologics' sale to Japanese manufacturer closes
The $10 billion Tokyo-based acquirer makes mainly nutritional additives and foods, but sees Grove City’s Forge as a launchpad for expanding its healthcare arm into advanced medicine.